+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry



Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry



Pathology Research and Practice 213(9): 1139-1143



Thymosin beta-4 (Tβ4) is a protein that is linked to a number of important biological actions and recently tumor progression and poor prognosis of some tumors. The aim of this study was to evaluate Tβ4 expression in gastric GISTs and correlate with some clinicopathological characteristics related with prognosis and clinical outcome in order to add further data to the current literature. Tβ4 antibody was applied to the 4μm-thick paraffin sections of 57 gastric GISTs by immunohistochemistry. Tβ4 expression was found to be directly corrrelated with higher risk groups, tumor size, mitotic count, cellularity, and necrosis while it was inversely correlated with overall survival (OS) by univariate analysis (p=0.000, p=0.001, p=0.000, p=0.025, p=0.023, and p=0.042, respectively). The direct association between Tβ4 expression and risk groups were also supported by multivariate analysis (p=0.000, β=0.497, t=4.374). Overexpression of Tβ4 was found to be related with predictive characteristics for tumor progression and adverse prognosis. Thus, we suggest that overexpression of Tβ4 might play a role in the progression of gastric GISTs and might be used as a potential prognostic tool as well as a target for novel therapies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060402992

Download citation: RISBibTeXText

PMID: 28756979

DOI: 10.1016/j.prp.2017.07.005


Related references

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Annals of Diagnostic Pathology 11(1): 27-33, 2007

Analysis of risk factors of gastrointestinal stromal tumors in different age groups based on SEER database. Scandinavian Journal of Gastroenterology 54(4): 480-484, 2019

The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry. Annali Italiani di Chirurgia 88: 311-317, 2017

A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST). Journal of Gastrointestinal Surgery 22(12): 2150-2157, 2018

Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors. Hepato-Gastroenterology 50(53): 1431-1435, 2003

Retrospective study of laparoscopic versus open gastric resection for gastric gastrointestinal stromal tumors based on the propensity score matching method. Surgical Endoscopy 31(1): 374-381, 2017

Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis. Journal of Cancer Research and Therapeutics 14(Supplement): S243-S247, 2018

Clinical characteristics and prognostic analysis of 45 patients with high-risk gastrointestinal stromal tumors. Zhonghua Wei Chang Wai Ke Za Zhi 16(3): 251-255, 2013

Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach. International Journal of Colorectal Disease 28(8): 1057-1064, 2013

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Research 63(9): 2188-2193, 2003

Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. American Journal of Surgical Pathology 34(1): 53-64, 2010

Endoscopic submucosal dissection for gastric gastrointestinal stromal tumors: a retrospective cohort study. Surgical Endoscopy 31(11): 4522-4531, 2017

Endoscopy-Assisted Laparoscopic Resections for Gastric Gastrointestinal Stromal Tumors: A Retrospective Study. Journal of Laparoendoscopic and Advanced Surgical Techniques. Part a 27(2): 110-114, 2017

Laparoscopic management of gastric gastrointestinal stromal tumors: A retrospective 10-year single-center experience. World Journal of Gastroenterology 23(19): 3522-3529, 2017

Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors. Journal of Clinical Medicine 7(11):, 2018